A case of rivaroxaban associated spontaneous hemothorax
| Autor: | Pinar Ozmen Yildiz, Ebubekir Aksu, İbrahim Yıldız, İsmail Gürbak |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Pulmonary and Respiratory Medicine
Rivaroxaban business.industry Warfarin Case Report Safety margin Atrial fibrillation 030204 cardiovascular system & hematology medicine.disease 03 medical and health sciences 0302 clinical medicine Anesthesia Spontaneous hemothorax Medicine Surgery In patient 030212 general & internal medicine Cardiology and Cardiovascular Medicine business medicine.drug |
| Zdroj: | The Turkish Journal of Thoracic and Cardiovascular Surgery. 27:118-120 |
| ISSN: | 2149-8156 1301-5680 |
| DOI: | 10.5606/tgkdc.dergisi.2019.15090 |
| Popis: | New oral anticoagulants have emerged as an alternative for warfarin for thromboembolic prevention in patients with nonvalvular atrial fibrillation. Although new oral anticoagulants have better compliance and safety margin compared to warfarin, we must be cautious with their usage. In this article, we report a case of spontaneous hemothorax related to rivaroxaban treatment. According to our research, this is the first case of spontaneous hemothorax secondary to rivaroxaban treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|